Investor Presentaiton slide image

Investor Presentaiton

Steady Focus on Balance Sheet continues Debtor Days 31 31 Mar-22 Dec-22 OCF to EBIDTA 96% 99% FY22 9MFY23 Working Capital Days 19 14 Mar-22 Dec-22 Cash and Cash Equivalents Rs. In Crs 181 131 Mar-22 WC Days (CA- Cash & Equivalents) - (CL - Lease liabilities - Borrowings) / TTM Sales *365 = OCF / EBITDA = CFO before tax / EBITDA Dec-22 METROPOLIS The Pathology Specialist Key Highlights ✓ Debtor days in Dec-22 at stable levels compared to Mar-22 ✓ Cash & Cash Equivalents dropped on account of prepayment of loan taken for acquisition of Hitech ✓ Gross debt stood at Rs. 111.4 Crs as of Dec-22. Plan to repay by FY24 Working Capital days increased by 5 days due to decrease in creditor days by 6 days ✓ OCF / EBITDA stood at 99% 21
View entire presentation